Monthly administration of long-acting injectable risperidone and striatal dopamine D2 receptor occupancy for the management of schizophrenia

Hiroyuki Uchida, David C. Mamo, Shitij Kapur, Alain Labelle, Chekkera Shammi, Erik J.L. Mannaert, Steve W. Mann, Gary Remington

Research output: Contribution to journalArticlepeer-review

44 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Monthly administration of long-acting injectable risperidone and striatal dopamine D<sub>2</sub> receptor occupancy for the management of schizophrenia'. Together they form a unique fingerprint.

Medicine & Life Sciences